Procter & Gamble Health Limited
Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals
Key metrics
Price as of 2026-07-20
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
|---|---|---|---|---|
| Sales | 934 Cr | 339 Cr | 325 Cr | 374 Cr |
| Operating expenses (approx.) | 605 Cr | 244 Cr | 200 Cr | 259 Cr |
| EBITDA | 329 Cr | 94 Cr | 125 Cr | 115 Cr |
| OPM % | 35.2% | 27.9% | 38.5% | 30.7% |
| Other income | 10 Cr | 4 Cr | 5 Cr | 4 Cr |
| Interest | 0.43 Cr | 0.12 Cr | 0.12 Cr | 0.10 Cr |
| Depreciation | 17 Cr | 5 Cr | 6 Cr | 6 Cr |
| Profit before tax | 312 Cr | 89 Cr | 119 Cr | 109 Cr |
| Tax % | 24.8% | 25.5% | 25.6% | 28.7% |
| Net profit | 234 Cr | 66 Cr | 89 Cr | 78 Cr |
| EPS (₹) | ₹141.22 | ₹39.87 | ₹53.34 | ₹46.74 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | TTM |
|---|---|
| Sales | Sign in for TTM |
| Operating expenses (approx.) | Sign in for TTM |
| EBITDA | Sign in for TTM |
| OPM % | Sign in for TTM |
| Other income | Sign in for TTM |
| Interest | Sign in for TTM |
| Depreciation | Sign in for TTM |
| Profit before tax | Sign in for TTM |
| Tax % | Sign in for TTM |
| Net profit | Sign in for TTM |
| EPS (₹) | Sign in for TTM |
| Dividend payout % | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
No data for this view.
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
No data for this view.
Ratios
Ratios as reported or derived per annual period.
No data for this view.
Compare with peers
Loading peers…